PUBLISHER: The Insight Partners | PRODUCT CODE: 1181571
PUBLISHER: The Insight Partners | PRODUCT CODE: 1181571
The nerve repair & regeneration market in the Middle East & Africa is expected to grow from US$ 300.76 million in 2022 to US$ 494.31 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2022 to 2028.
Product Launches and Approvals
Nerve repair and regeneration offers products such as neuromodulators, neurostimulation, and biomaterial devices. These devices are utilized for the treatment of neurodegenerative or traumatic disorders such as Parkinson's disease, Alzheimer's disease, sclerosis, multiple system atrophy, and amyotrophic lateral sclerosis. Therefore, market players are launching various products such as internal neurostimulation devices, external neurostimulation devices, nerve conduits, nerve wraps, nerve connectors, and other biomaterials enhance the treatment output of nerve repair and regeneration. A few of the recent developments related to the nerve repair and regeneration market are In July 2022, Checkpoint Surgical launched the Checkpoint Edge Nerve Cutting Kit, expanding the strength of the intraoperative nerve care portfolio of the company. The Checkpoint Edge Nerve Cutting Kit is the first offering in the planned portfolio of nerve-specific instruments by Checkpoint Surgical, with further expansion planned in the future.
Similarly, In Mar-2022: Integra LifeSciences Holding Corporation launched the NeuraGen 3D Nerve Guide Matrix, which is a resorbable implant for the repair of peripheral nerve discontinuities. NeuraGen 3D is a nerve repair product specifically engineered to develop an optimized environment that enables a greater complete functional recovery following mid-gap nerve repair in comparison to hollow nerve conduits alone. Further, In Aug 2021, Checkpoint Surgical, Inc. launched the NeuroShield Chitosan Nerve Wrap to expand its intraoperative nerve care product line. The NeuroShield Wrap marks is the first product in a planned line of chitosan-based biological implants of the company to support nerve healing. Adding the product, complements the existing product portfolio of Checkpoint Surgical, including the company's flagship Checkpoint Nerve Stimulator/Locator, the leading nerve stimulation device for intraoperative nerve protection and repair. Thus, the active participation of market players in product innovation and development and increase in approvals of products are likely to fuel the market growth in the coming years.
Market Overview
The Middle East & Africa nerve repair & regeneration market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The growing prevalence of neurological disorders and a surge in research and development activities are driving the growth of the nerve repair & regeneration market. According to WHO, ~80% of strokes are expected to occur in low- and middle-income countries. According to Alzheimer's disease International, the number of people having Alzheimer's disease is expected to reach 131.5 million by 2050 in low-and middle-income countries. As per the American Academy of Neurology, in 2022, ~17.6 million (11.7%) DALYs were reported in the region. In the UAE, stroke and dementia are the leading causes of disability-adjusted life years (DALYs) and death. According to WHO, in 2020, in the UAE, ~0.51% of total deaths were due to Parkinson's disease. The growing geriatric population is significantly increasing the prevalence of Alzheimer's disease. Thus, the increasing prevalence of neurological diseases among the geriatric population of the UAE is driving the growth of the nerve repair & regeneration market.
Middle East & Africa Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Nerve Repair & Regeneration Market Segmentation
The Middle East & Africa nerve repair & regeneration market is segmented into product, application, and country.
Based on simulator type, the market is segmented into neurostimulation and neuromodulation devices and biomaterial s. The neurostimulation and neuromodulation devices segment registered the largest market share in 2022.
Based on application, the market is categorized into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held the largest market share in 2022.
Based on country, the Middle East & Africa nerve repair & regeneration market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Further, the Rest of MEA dominated the market in 2022.
Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in the Middle East & Africa.